Prima Mente is a frontier biology and AI research company focused on building general-purpose biological foundation models to understand the brain, protect it from neurological disease, and enhance it in health. The company integrates artificial intelligence, experimental biology, and clinical research to generate new insights into brain function and disease mechanisms.

Its research platform includes large-scale foundation models such as the Pleiades series, which model whole-genome epigenetic data, and the Parthenon series, which focuses on multi-omic representations of brain cell types. These models are designed to discover disease signatures, identify novel therapeutic targets, and improve understanding of neurological conditions such as Alzheimer’s and Parkinson’s disease.

Prima Mente also conducts large-scale clinical research through programs such as SANDBOX and READOUT, combining biomarkers, genotyping, and remote cognitive testing across real-world healthcare settings. The company positions itself at the intersection of AI, biology, and clinical neuroscience, translating data-rich research into improved detection, prevention, and treatment of neurological disease.